本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pyxis Oncology, Inc.

1.02
-0.0400-3.77%
盘后1.020.00000.00%16:30 EDT
成交量:207.31万
成交额:218.30万
市值:6,282.22万
市盈率:-0.77
高:1.16
开:1.08
低:1.01
收:1.06
数据加载中...
2023/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/30

重要事件披露

Form 8-K - Current report
2023/06/30

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/06/29

SEC问询函

Form CORRESP - Correspondence
2023/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/14

重要事件披露

Form 8-K - Current report
2023/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/30

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/05/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/05/25

重要事件披露

Form 8-K - Current report
2023/05/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/05/24

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/05/24

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/05/24

重要事件披露

Form 8-K - Current report
2023/05/24

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/10

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership